{"id":"NCT01261611","sponsor":"Ipsen","briefTitle":"Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia","officialTitle":"A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short-term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (Dysport and Dysport NG) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport NG Following Repeated Treatments of Subjects With Cervical Dystonia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2012-05","completion":"2013-06","firstPosted":"2010-12-16","resultsPosted":"2019-09-24","lastUpdate":"2022-09-28"},"enrollment":382,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cervical Dystonia"],"interventions":[{"type":"BIOLOGICAL","name":"Botulinum toxin type A","otherNames":["AbobotulinumtoxinA (DysportRU®)"]},{"type":"BIOLOGICAL","name":"Botulinum toxin type A","otherNames":["AbobotulinumtoxinA (Dysport®)"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dysport NG","type":"EXPERIMENTAL"},{"label":"Dysport","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate how well a new drug called Dysport NG works and how safe it is, when it is used for the treatment of cervical dystonia. Dysport NG will be compared to an approved drug called Dysport.","primaryOutcome":{"measure":"Change From Baseline in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) Total Score Following First Treatment Cycle","timeFrame":"Baseline and Week 4","effectByArm":[{"arm":"Dysport NG","deltaMin":-12.46,"sd":null},{"arm":"Dysport","deltaMin":-13.99,"sd":null},{"arm":"Placebo","deltaMin":-3.93,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":57,"countries":["Australia","Austria","Belgium","Czechia","France","Germany","Hungary","Poland","Portugal","Russia","Ukraine"]},"refs":{"pmids":["27653448"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":4},"commonTop":["Dysphagia","Nasopharyngitis","Muscular weakness"]}}